ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

ACOR Opens Cancer-pain.org

March 2, 2001

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

In Brief: Increasing Survival Through Adjuvant Therapy Seen As Adding To Cost Of Care

October 24, 1975

Funding Opportunities Listed (12-page issue).

July 11, 2003

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

More Oncopathology Research Asked

June 30, 1978